Torthaí cuardaigh - Matthieu Ponsoye
- 1 - 3 toradh as 3 á dtaispeáint
-
1
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis de réir Nadira Ruzehaji, C. Frantz, Matthieu Ponsoye, Jérôme Avouac, Sonia Pezet, Thomas Guilbert, Jean‐Michel Luccarini, Pierre Broqua, Jean‐Louis Junien, Yannick Allanore
Foilsithe / Cruthaithe 2016Artigo -
2
OX40L blockade protects against inflammation-driven fibrosis de réir Muriel Elhaï, Jérôme Avouac, Anna‐Maria Hoffmann‐Vold, Nadira Ruzehaji, O. Amiar, Barbara Ruiz, Hassina Brahiti, Matthieu Ponsoye, Maxime Fréchet, Anne Burgevin, Sonia Pezet, Jérémy Sadoine, Thomas Guilbert, Carole Nicco, Hisaya Akiba, Vigo Heissmeyer, Arun Subramaniam, Robert Resnick, Øyvind Molberg, André Kahan, Gilles Chiocchia, Yannick Allanore
Foilsithe / Cruthaithe 2016Artigo -
3
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis de réir Mathilde Roumier, Romain Paule, Alexandre Vallée, Julien Rohmer, Marie Ballester, Anne‐Laure Brun, Charles Cerf, Marie-Laure Chabi, Thierry Chinet, Marie-Alice Colombier, Éric Farfour, Erwan Fourn, Guillaume Géri, D. Khau, Ibrahim Marroun, Matthieu Ponsoye, A. Roux, Hélène Salvator, Y. Schoindre, Anne-Gaëlle Si Larbi, Colas Tchérakian, Marc Vasse, Anne Verrat, Benjamin Zuber, Louis‐Jean Couderc, Jean‐Emmanuel Kahn, Matthieu Groh, Félix Ackermann
Foilsithe / Cruthaithe 2020Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Biochemistry
Biology
Disease
Fibrosis
Immunology
Inflammation
Receptor
2019-20 coronavirus outbreak
Agonist
Betacoronavirus
Biomarker
Biotechnology
Bleomycin
Blockade
CTGF
Cancer research
Chemotherapy
Clinical significance
Coronavirus disease 2019 (COVID-19)
Downregulation and upregulation
Endocrinology
Gene
Growth factor
In vivo
Infectious disease (medical specialty)
Intensive care medicine
Lung fibrosis
Medical microbiology